Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? (Q74581597)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Lauren E Abrey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Howard T Thaler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Raja B Khan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Weiji Shi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

175-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12164690%20AND%20SRC:MED&resulttype=core&format=json

Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

11 November 2019

cites work

1 reference

12 December 2020

Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas

1 reference

12 December 2020

Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study

1 reference

12 December 2020

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group

1 reference

12 December 2020

Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion

1 reference

12 December 2020

Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis

1 reference

12 December 2020

Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients

1 reference

12 December 2020

Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with nonHodgkin's lymphoma

1 reference

12 December 2020

Leptomeningeal tumor in primarchy central nervous system lymphoma: Recognition, significance, and implications

1 reference

12 December 2020

Treatment for primary CNS lymphoma: the next step

1 reference

12 December 2020

Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases

1 reference

12 December 2020